Powder: -20°C for 3 years | In solvent: -80°C for 1 year
YK11 是雄激素受体部分激动剂,当使用浓度为 0.1 μM 时,可激活过表达雄激素受体的 HEK293 细胞中的雄激素受体转录活性,具有成骨活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 222 | 现货 | ||
2 mg | ¥ 297 | 现货 | ||
5 mg | ¥ 513 | 现货 | ||
10 mg | ¥ 825 | 现货 | ||
50 mg | ¥ 969 | 现货 | ||
100 mg | ¥ 1,230 | 现货 | ||
500 mg | ¥ 3,130 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 913 | 现货 |
产品描述 | YK11 is an androgen receptor partial agonist that activates androgen receptor transcriptional activity in HEK293 cells overexpressing androgen receptors when used at a concentration of 0.1 μM, with osteogenic activity. |
体外活性 | The induction of key myogenic regulatory factors (MRFs), such as myogenic differentiation factor (MyoD), myogenic factor 5 (Myf5) and myogenin, was more significant in the presence of YK11 than in the presence of DHT. YK11 treatment of C2C12 cells, but not DHT, induced the expression of follistatin (Fst), and the YK11-mediated myogenic differentiation was reversed by anti-Fst antibody. Suggest that the induction of Fst is important for the anabolic effect of YK11[1]. |
别名 | (17ALPHA,20E)-17,20-[(1-甲氧基乙亚基)二(氧基)]-3-氧代-19-去甲孕甾-4,20-二烯-21-羧酸甲酯 |
分子量 | 430.53 |
分子式 | C25H34O6 |
CAS No. | 1370003-76-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 64 mg/mL (148.65 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.3227 mL | 11.6136 mL | 23.2272 mL | 58.068 mL |
5 mM | 0.4645 mL | 2.3227 mL | 4.6454 mL | 11.6136 mL | |
10 mM | 0.2323 mL | 1.1614 mL | 2.3227 mL | 5.8068 mL | |
20 mM | 0.1161 mL | 0.5807 mL | 1.1614 mL | 2.9034 mL | |
50 mM | 0.0465 mL | 0.2323 mL | 0.4645 mL | 1.1614 mL | |
100 mM | 0.0232 mL | 0.1161 mL | 0.2323 mL | 0.5807 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
YK11 1370003-76-1 Endocrinology/Hormones Androgen Receptor YK 11 (17ALPHA,20E)-17,20-[(1-甲氧基乙亚基)二(氧基)]-3-氧代-19-去甲孕甾-4,20-二烯-21-羧酸甲酯 Inhibitor YK-11 inhibit inhibitor